Nuzenio

Agios Pharmaceuticals In

Agios Pharmaceuticals In news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds - simplywall.stsimplywall.st · Sat, 08 Aug 2026 20:21:55 GMTFARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals In - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:27:48 GMTHow Surging Revenue With Ongoing Losses Will Impact Agios Pharmaceuticals (AGIO) Investors - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMTFarallon Capital (AGIO) discloses 5.9M-share, 9.9% position in Agios - Stock TitanStock Titan · Mon, 03 Aug 2026 12:30:48 GMTAgios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $45.38, Implies 39% Upside - TradingViewTradingView · Fri, 31 Jul 2026 07:00:00 GMTAgios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $43.12, Implies 23% Upside - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTAgios Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AGIO) 2026-07-30 - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTBiotechs bring big launches and pharma rivalries into Q2 earnings period - BioSpaceBioSpace · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 20:21:55 GMTAgios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds - simplywall.st
Sat, 08 Aug 2026 08:27:48 GMTFARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals In - GuruFocus
Thu, 06 Aug 2026 07:00:00 GMTHow Surging Revenue With Ongoing Losses Will Impact Agios Pharmaceuticals (AGIO) Investors - Sahm
Mon, 03 Aug 2026 12:30:48 GMTFarallon Capital (AGIO) discloses 5.9M-share, 9.9% position in Agios - Stock Titan
Fri, 31 Jul 2026 07:00:00 GMTAgios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $45.38, Implies 39% Upside - TradingView
Thu, 30 Jul 2026 07:00:00 GMTAgios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $43.12, Implies 23% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Agios Pharmaceuticals In.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.